| Exosomal miRNA profile as complementary tool in the diagnostic and prediction of treatment response in localized breast cancer under neoadjuvant chemotherapy A Rodríguez-Martínez, D de Miguel-Pérez, FG Ortega, JL García-Puche, ... Breast Cancer Research 21, 1-9, 2019 | 149 | 2019 |
| Circulating tumor cells identify early recurrence in patients with non-small cell lung cancer undergoing radical resection C Bayarri-Lara, FG Ortega, A Cueto Ladrón de Guevara, JL Puche, ... PloS one 11 (2), e0148659, 2016 | 128 | 2016 |
| Extracellular vesicle-miRNAs as liquid biopsy biomarkers for disease identification and prognosis in metastatic colorectal cancer patients D de Miguel Pérez, A Rodriguez Martínez, A Ortigosa Palomo, ... Scientific reports 10 (1), 3974, 2020 | 102 | 2020 |
| Liquid biopsy tracking of lung tumor evolutions over time A Russo, D De Miguel Perez, M Gunasekaran, K Scilla, R Lapidus, ... Expert review of molecular diagnostics 19 (12), 1099-1108, 2019 | 60 | 2019 |
| Cooperative and Escaping Mechanisms between Circulating Tumor Cells and Blood Constituents C Garrido-Navas, D de Miguel-Pérez, J Exposito-Hernandez, C Bayarri, ... Cells 8 (11), 1382, 2019 | 53 | 2019 |
| Interfering with endolysosomal trafficking enhances release of bioactive exosomes FG Ortega, MT Roefs, D de Miguel Perez, SA Kooijmans, OG de Jong, ... Nanomedicine: Nanotechnology, Biology and Medicine 20, 102014, 2019 | 53 | 2019 |
| Extracellular vesicle PD-L1 dynamics predict durable response to immune-checkpoint inhibitors and survival in patients with non-small cell lung cancer D de Miguel-Perez, A Russo, O Arrieta, M Ak, F Barron, M Gunasekaran, ... Journal of Experimental & Clinical Cancer Research 41 (1), 186, 2022 | 48 | 2022 |
| miRNA in situ hybridization in circulating tumor cells-MishCTC FG Ortega, JA Lorente, JL Garcia Puche, MP Ruiz, RM Sanchez-Martin, ... Scientific reports 5 (1), 9207, 2015 | 47 | 2015 |
| Sandwich-type electrochemical paper-based immunosensor for claudin 7 and CD81 dual determination on extracellular vesicles from breast cancer patients FG Ortega, MD Regiart, A Rodríguez-Martínez, D de Miguel-Pérez, ... Analytical Chemistry 93 (2), 1143-1153, 2020 | 35 | 2020 |
| Improving extracellular vesicles visualization: From static to motion P Reclusa, P Verstraelen, S Taverna, M Gunasekaran, M Pucci, I Pintelon, ... Scientific reports 10 (1), 6494, 2020 | 34 | 2020 |
| Post-surgery circulating tumor cells and AXL overexpression as new poor prognostic biomarkers in resected lung adenocarcinoma D de Miguel-Pérez, CI Bayarri-Lara, FG Ortega, A Russo, ... Cancers 11 (11), 1750, 2019 | 34 | 2019 |
| Next generation sequencing for liquid biopsy based testing in non-small cell lung cancer in 2021 P Pisapia, JL Costa, F Pepe, G Russo, G Gragnano, A Russo, A Iaccarino, ... Critical Reviews in Oncology/Hematology 161, 103311, 2021 | 30 | 2021 |
| Liquid biopsy from research to clinical practice: focus on non-small cell lung cancer U Malapelle, P Pisapia, A Addeo, O Arrieta, B Bellosillo, AF Cardona, ... Expert review of molecular diagnostics 21 (11), 1165-1178, 2021 | 28 | 2021 |
| Circulating tumor cells criteria (CyCAR) versus standard RECIST criteria for treatment response assessment in metastatic colorectal cancer patients M Delgado-Ureña, FG Ortega, D de Miguel-Pérez, A Rodriguez-Martínez, ... Journal of Translational Medicine 16, 1-11, 2018 | 26 | 2018 |
| Exchange of cellular components between platelets and tumor cells: impact on tumor cells behavior A Rodriguez-Martinez, I Simon-Saez, S Perales, C Garrido-Navas, ... Theranostics 12 (5), 2150, 2022 | 21 | 2022 |
| STK11 and KEAP1 mutations in non-small cell lung cancer patients: Descriptive analysis and prognostic value among Hispanics (STRIKE registry-CLICaP) VCC de Lima, M Corassa, E Saldanha, H Freitas, O Arrieta, L Raez, ... Lung Cancer 170, 114-121, 2022 | 19 | 2022 |
| Bispecific Antibodies in Cancer Immunotherapy: A Novel Response to an Old Question C Ordóñez-Reyes, JE Garcia-Robledo, DF Chamorro, A Mosquera, ... Pharmaceutics 14 (6), 1243, 2022 | 19 | 2022 |
| Liquid biopsy beyond of cancer: Circulating pulmonary cells as biomarkers of COPD aggressivity PJ Romero-Palacios, B Alcázar-Navarrete, JJD Mochón, ... Critical reviews in oncology/hematology 136, 31-36, 2019 | 17 | 2019 |
| Association of circulating tumour cells with early relapse and 18F-fluorodeoxyglucose positron emission tomography uptake in resected non-small-cell lung cancers CI Bayarri-Lara, D de Miguel Pérez, A Cueto Ladrón de Guevara, ... European Journal of Cardio-Thoracic Surgery 52 (1), 55-62, 2017 | 17 | 2017 |
| Baseline extracellular vesicle TGF‐β is a predictive biomarker for response to immune checkpoint inhibitors and survival in non–small cell lung cancer D de Miguel‐Perez, A Russo, M Gunasekaran, F Buemi, L Hester, X Fan, ... Cancer 129 (4), 521-530, 2023 | 16 | 2023 |
